A Novel Anti-PD-L1 Antibody Exhibits Antitumor Effects on Multiple Myeloma in Murine Models via Antibody-Dependent Cellular Cytotoxicity

Multiple myeloma is a malignant cancer of plasma cells. Despite recent progress with immunomodulatory drugs and proteasome inhibitors, it remains an incurable disease that requires other strategies to overcome its recurrence and non-response. Based on the high expression levels of programmed death-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Jae-Hee, Lee, Byung-Hyun, Kim, Seong-Eun, Kwon, Bo-Eun, Jeong, Hyunjin, Choi, Jong Rip, Kim, Min Jung, Park, Yong, Kim, Byung Soo, Kim, Dae Hee, Ko, Hyun-Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921862/
https://www.ncbi.nlm.nih.gov/pubmed/33139584
http://dx.doi.org/10.4062/biomolther.2020.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921862/
https://www.ncbi.nlm.nih.gov/pubmed/33139584
http://dx.doi.org/10.4062/biomolther.2020.131

Ejemplares similares